Squeezer is a platform that helps software developers build apps easily without tackling the entire blockchain infrastructure. It is also a powerful tool for providing high-quality blockchain software components to large enterprise organizations. Squeezer uses world-class microservices platforms, such as AWS Lambda, Google Functions, and Azure Functions.

INVERSE is a DeFi based platform that provides an array of smart-contract features with integrated time-based options. Users have the opportunity to speculate on the drop in value of a suite of Defi coins by utilizing the multiple 'tracking vaults' on the platform. XIV, the protocol's native token, is used to unlock these vaults, and then staked within these vaults for no more than 7 days. As their name implies, these vaults track the real-time price movements of select DeFi tokens (i.e. COMP, AAVE, UNI, YFI). After 7 days, if the value of the DeFi asset being tracked has dropped by a certain percentage, the user will gain a significant percentage yield on the amount of XIV held within the tracking vault. If the price of the DeFi asset does not drop in value beyond the predetermined percentage by the end of the 7-day staking period, the user will forfeit a portion of their staked XIV. Rewards will be automatically disbursed to the user’s web3 browser wallet at the end of the 7-day staking period. Ultimately, INVERSE offers users the option to hedge against the volatility of select crypto assets.

Aimedis is an AI backed, blockchain and smart contract supported medical ecosystem, that changes the way patients, doctors, and hospitals communicate, connect and handle information. Using the Aimedis platform, users can store, secure and share their medical information only with the people they want to share it with by using the Aimedis right management system. Beside the records, AImedis offers videochat and communication with other patients and doctors, online prescriptions, online appointments, learning content, the inclusion of fitness trackers and devices like ECG or bloodpressure monitors into the system, while all transactions inside the system are backed by our porprietary private AIMChain blockchain, while the token is bound to a public blockchain (Aimedis dual-blockchain model). AIMSocial will be the new incentivised and decentralized medical social network where patients can help other patients and get rewarded for it, while the system is supported by AI.

Based in the United States, Moonlighting is a 3-year-old freelance marketplace with a proven track record of empowering people to earn extra money and hire talented professionals quickly. With the integration of blockchain technology Moonlighting will decentralize worker profiles, reward participation, and make hiring and working in the freelance economy trusted, global, and inclusive.

Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.

ORION is a new kind of blockchain investment platform that combines the best features of exchanges, brokerages, and instant trading apps. The platform is built around a liquidity aggregator connected to all of the major crypto exchanges, as well as its own internal decentralized exchange, enabling users to gain the best price for their trades from a single portal. Along with powerful tools for portfolio management, ORION offers exceptional security, convenience, and flexibility. The platform is suitable for experienced traders, institutional investors, and newcomers alike.